Compare RH & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RH | ATRC |
|---|---|---|
| Founded | 1979 | 2000 |
| Country | United States | United States |
| Employees | 7230 | N/A |
| Industry | Other Specialty Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.5B |
| IPO Year | 2011 | 2005 |
| Metric | RH | ATRC |
|---|---|---|
| Price | $112.65 | $56.10 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 20 | 10 |
| Target Price | ★ $165.82 | $55.78 |
| AVG Volume (30 Days) | 645.7K | ★ 1.3M |
| Earning Date | 09-10-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 74.31 | ★ 74.74 |
| EPS | ★ 2.36 | 0.18 |
| Revenue | ★ $1,193,046,000.00 | $201,630,000.00 |
| Revenue This Year | $5.70 | $13.42 |
| Revenue Next Year | $9.26 | $12.12 |
| P/E Ratio | ★ $50.18 | $320.89 |
| Revenue Growth | ★ 24.52 | 15.40 |
| 52 Week Low | $106.30 | $25.36 |
| 52 Week High | $239.40 | $61.70 |
| Indicator | RH | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 35.96 | 53.78 |
| Support Level | $106.30 | $26.95 |
| Resistance Level | $135.61 | $61.70 |
| Average True Range (ATR) | 4.72 | 2.35 |
| MACD | 0.84 | -0.26 |
| Stochastic Oscillator | 32.03 | 62.26 |
RH is a luxury furniture and lifestyle retailer primarily operating in the $136 billion domestic furniture and home furnishing industry. The firm offers merchandise across many categories, including furniture, lighting, textiles, bath, decor, and has a growing presence in hospitality with 27 restaurant locations, including RH Guesthouse. RH innovates, curates, and integrates products, categories, services, and businesses across design subcategories (RH Estates and Waterworks, for example), and has recently broadened its addressable market via expansion abroad (currently, less than 10% of sales) and its World of RH digital platform (highlighting offerings outside of home furnishings).
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.